Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysisResearch in context

Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysisResearch in context

Summary: Background: Atezolizumab-bevacizumab (atezo-bev) is recommended as first-line therapy for patients with unresectable hepatocellular carcinoma (uHCC). However, its effectiveness and safety in other populations, including those with Child-Turcotte-Pugh (CTP) class B cirrhosis, is unclear. Me...

Full description

Bibliographic Details
Main Authors: Anand V. Kulkarni, Harshvardhan Tevethia, Karan Kumar, Madhumita Premkumar, Mark D. Muttaiah, Atsushi Hiraoka, Takeshi Hatanaka, Toshifumi Tada, Takashi Kumada, Satoru Kakizaki, Arndt Vogel, Richard S. Finn, Padaki Nagaraja Rao, Anjana Pillai, Duvvur Nageshwar Reddy, Amit G. Singal
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:EClinicalMedicine
Subjects:
Immunotherapy
Liver cancer
Radiological response
Adverse events
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537023003565

Internet

http://www.sciencedirect.com/science/article/pii/S2589537023003565

Similar Items